Define the accepted material before the cost
A capture step is useful when it delivers material that meets the process requirements at the required rate. A low resin price does not settle that question. Loading, recovery, cleaning, lifetime and the effect on later steps can all change the economic comparison.
Protein A affinity capture is one part of an antibody-purification process. This article focuses on the purchasing and operating model for that step. Chromatography research covers the wider separation workflow. Keeping the scopes distinct avoids presenting every chromatography instrument or consumable as having the same demand driver and recurring-revenue economics.
Binding capacity needs its test conditions
Sartorius describes Protein A affinity chromatography as an approach to antibody capture. That establishes the function, not the suitability or economics of every product. Feed material, process conditions and the required output remain relevant to selection.
Cytiva's dynamic-binding-capacity note reports results under specified conditions. The important lesson for comparison is to retain those conditions, including residence time and the tested antibody. A supplier's favorable measurement should not be treated as a universal capacity for another feed or process.
The constraint is the complete operating cycle
A higher loading capacity may reduce resin volume, but the process also spends time equilibrating, loading, washing, eluting and cleaning. The fastest single step does not establish the shortest complete cycle. Changing the resin can also change the requirements placed on other equipment or later purification steps.
Reuse adds another dependency: useful performance has to persist across the intended lifetime. A calculation based on the first cycle alone can overstate lifetime productivity if capacity or recovery deteriorates. The appropriate evidence is process-specific performance through the relevant operating sequence, with the limits and acceptance criteria stated.
An illustrative lifetime-cost model
Suppose a hypothetical purchase costs $100,000 and supports 100 accepted cycles, each recovering 5 kilograms. The stated resin cost is $200 per recovered kilogram across that assumed lifetime. If only 50 cycles are acceptable, the resin-cost contribution doubles to $400 per kilogram under the same other assumptions.
These figures are invented, not market prices or measured resin performance. They exclude buffer, labor, equipment, validation, disposal and the cost of lost material. They show why lifetime, recovery and accepted output belong in the denominator. A real comparison should use the buyer's process evidence and include the changes required to adopt an alternative.
Qualification can support retention without guaranteeing returns
A supplier that consistently supports a qualified process can become difficult to replace, because a change requires work and carries operational consequences. That is a plausible retention mechanism, not a universal switching-cost multiple or proof of unlimited pricing power. The buyer can still develop alternatives or change the production process.
Supplier financial analysis should distinguish resin demand driven by actual production from inventory changes and equipment installations. A broad increase in antibody-development activity does not establish the timing or profitability of consumable purchases. Product relationships and reporting boundaries need evidence before translating the technical opportunity into company revenue.
What would change the conclusion
We would favor comparisons using the same feed and acceptance criteria, with cycle times, lifetime performance and process costs disclosed. A persuasive improvement reduces cost per acceptable output or removes a genuine throughput constraint. It should also explain implementation effort and any burden transferred to downstream processing.
The case weakens when quoted capacity fails to persist in use, when cleaning limits lifetime or when another purification approach delivers the required output with fewer costs. Our judgment is that resin economics must follow the full qualified cycle.